
You bought turmeric — but what did you actually buy?
Any pharmacy has a wall of golden bottles — some labeled turmeric, some curcumin, some both — priced from $8 to $45 for what looks like the same thing. It is not. The label difference between turmeric and curcumin, and whether the product has an absorption enhancer, makes a big difference to how much active compound reaches your bloodstream.
The uncomfortable truth: a 1,000 mg capsule of plain turmeric root powder may deliver only about 20–50 mg of curcuminoids, and much of that is broken down before it reaches your bloodstream. The knee-arthritis trials that compared curcumin with NSAIDs used concentrated, standardized extracts — not kitchen turmeric.
Take the free supplement quiz →
Turmeric vs curcumin: the difference that changes everything
Turmeric is the whole root — the bright orange-yellow spice. Curcuminoids are the bioactive polyphenols inside it, and curcumin is the most-studied one, responsible for most of the anti-inflammatory effects seen in the lab.
The problem is concentration. Raw turmeric root is only about 2–5% curcuminoids by weight, and a USDA analysis of turmeric supplements and spices found total curcuminoids ranged from 1.3 to 69.8 mg per 100 mg from product to product (Singh et al., 2024). A standardized 95%-curcuminoid extract delivers ~950 mg per 1,000 mg capsule versus ~20–50 mg from root powder; matching trial doses with plain spice would take roughly 20–50 g of turmeric a day — far more than anyone can eat.
Bottom line: plain turmeric is fine and cheap for cooking. The clinical trials used standardized extracts, so that is what the research below applies to.
The bioavailability problem
Even pure curcumin is barely absorbed — poorly water-soluble, rapidly metabolized in the gut and liver, and eliminated fast — so formulation matters as much as dose. In a small 1998 study co-authored by the founder of the company that sells BioPerine, 20 mg of piperine (black pepper extract) taken with 2 g of curcumin raised blood curcumin about 20-fold from a near-undetectable baseline (Shoba et al., 1998) — which is why so many products bundle in black pepper.
Newer delivery systems repackage curcumin physically:
- Phospholipid (Meriva): about 29x higher total curcuminoid absorption than a standard extract in one crossover study (Cuomo et al., 2011)
- Lipid-particle (Longvida): higher absorption than plain curcumin; the size of the boost varies by study
- Submicron (Theracurmin): ~27x higher blood exposure than plain curcumin powder in healthy volunteers (Sasaki et al., 2011)
- Micellar (NovaSOL) and turmeric-oil matrix (BCM-95): other enhanced-absorption formats
A lower dose of a well-formulated product can deliver more curcumin than a higher dose of a cheap one. But note the trade-off covered in the safety section: these high-absorption forms are also the ones most linked to rare liver injury.
What the evidence actually supports
Osteoarthritis — limited evidence. Meta-analyses of mostly small trials find curcumin extracts reduce knee pain more than placebo and about as much as NSAIDs in the short term, with fewer stomach side effects — but the authors say the evidence is too weak for firm recommendations (Feng et al., 2022, 15 trials, 1,670 patients; Bannuru et al., 2018). Many trials are small and industry-funded, so the effect may be overstated.
Limited to moderate evidence, mostly from small trials. Curcumin lowers the blood inflammation marker CRP in meta-analyses, most clearly at ≤1,000 mg/day for more than 10 weeks — a lab change, not proof of feeling better (Gorabi et al., 2022). A meta-analysis of 6 small trials (377 patients) found a modest antidepressant effect versus placebo (Ng et al., 2017) — trials lasted only 4–8 weeks, so treat it as a possible adjunct, never a replacement for treatment. A meta-analysis of exercise trials found small reductions in post-exercise muscle soreness (Fang & Nasir, 2021). It may also modestly improve blood sugar and blood lipids in type 2 diabetes, but the evidence is less certain.
Weak or no evidence. Human trials on memory and cognition are small and inconsistent, and cancer outcomes in humans have been unconvincing. Ignore both marketing claims.

| Use case | Evidence grade | Practical verdict |
|---|---|---|
| Osteoarthritis / joint pain | Limited (small, short, partly maker-funded trials) | Best-studied use; similar to NSAIDs in small, short trials, but too weak for firm recommendations |
| Inflammation (CRP) | Moderate | Lab marker falls at ≤1,000 mg/day, 10+ weeks |
| Depression / mood | Limited | Possible adjunct only; 6 small, short trials |
| Blood sugar / lipids | Limited | May help slightly; not a substitute for medication |
| Exercise recovery | Moderate | Small effect on soreness |
| Cognition / Alzheimer's | Limited | Do not count on it |
| Cancer | Insufficient | Ignore the marketing |
How to dose it (and what to look for)
- Trial doses: 500–2,000 mg/day of a 95%-curcuminoid extract, split in two; ~1,000–1,500 mg/day is common. These are short-term trial doses; long-term safety above food-level intake is not established
- Take with food containing fat — curcumin is fat-soluble
- Be patient: trials ran 8–12 weeks
- More is not better: higher doses bring more stomach upset without clear extra benefit
On the label: the word curcumin or curcuminoids (not just turmeric), standardized to 95% curcuminoids, and third-party testing (such as USP or NSF). Before you buy, read the liver-safety section below — "high-absorption" and piperine forms are the ones most linked to rare liver injury. View third-party-tested 95% curcumin extracts on Amazon or, if you choose a piperine-free enhanced form knowing the liver caution applies to it too, view Meriva / Theracurmin formulas on Amazon.
Safety: the liver news you need before you buy
Curcumin is generally well tolerated in trials; mild stomach upset is the most common complaint. But the U.S. Drug-Induced Liver Injury Network has documented turmeric-associated liver injury — 10 cases in one series, including one fatal acute liver failure (DILIN case series) — and the NIH LiverTox monograph rates turmeric a well-documented cause of liver injury, typically appearing one to four months after starting. LiverTox notes that turmeric appears to have become the most common cause of herbal-related liver injury in the United States, and links many cases to high-bioavailability formulations, including those with piperine. Rare but real: stop and see a doctor if you develop fatigue, dark urine, or yellowing skin.
Avoid it or use caution with existing liver disease, pregnancy, gallbladder disease or gallstones (turmeric stimulates bile flow), blood thinners or antiplatelet drugs, upcoming surgery (stop ~2 weeks before), iron deficiency (high doses can impair non-heme iron absorption), and diabetes medication (additive glucose lowering). If your product contains piperine/BioPerine, check any prescription drugs too, since piperine changes how some drugs are absorbed and broken down. On any prescription? Clear it with your clinician or pharmacist first.
The bottom line
Turmeric is not curcumin. The best-studied use — knee osteoarthritis — rests on small, low-quality trials, and the brain and cancer claims are not supported. If you buy curcumin, choose a third-party-tested 95% extract, take it with a fat-containing meal at trial doses for 8–12 weeks, and know that "high-absorption" and piperine forms are the ones most linked to rare liver injury. Not sure joint support is your biggest gap? Our free quiz shows what your diet actually leaves on the table.